Shukra Pharmaceuticals Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

40.13 -2.11 (-5.00%)Updated : 13 Feb 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	22.86	57.22	55.31	19.26
Other Net	2.65	2.81	1.17	0.08
Total Adjustmentsto Net Income	0.00	-	0.00	-
Diluted Weighted Average Shares	43.79	437.88	67.24	300.95
Depreciation/ Amortization	3.00	2.05	1.84	1.66
Operating Income	9.72	17.35	3.53	1.22
Net Income	9.58	18.54	4.41	0.75
Income Availableto Com Excl Extra Ord	9.58	18.54	4.41	0.75
Other Operating Expenses Total	0.25	5.04	3.26	2.35
Net Income Before Taxes	13.34	19.88	4.44	1.02
Net Income After Taxes	9.58	18.54	4.41	0.75
Income Availableto Com Incl Extra Ord	9.58	18.54	4.41	0.75
Costof Revenue Total	8.11	44.49	45.32	10.35
Gross Profit	24.48	30.09	13.52	10.14
Interest Inc( Exp) Net- Non- Op Total	0.96	-0.28	-0.26	-0.28
Diluted Net Income	9.58	18.54	4.41	0.75
DPS- Common Stock Primary Issue	0.01	0.01	0.00	0.00
Provisionfor Income Taxes	3.76	1.35	0.04	0.27
period Type	-	-	-	-
Net Income Before Extra Items	9.58	18.54	4.41	0.75
Total Revenue	32.59	74.57	58.83	20.49
period Length	12.00	12.00	12.00	12.00
Revenue	32.59	74.57	58.83	20.49
Selling/ General/ Admin Expenses Total	11.50	5.65	4.89	4.90
Diluted Normalized EPS	0.22	0.04	0.07	0.00
Diluted EPS Excluding Extra Ord Items	0.22	0.04	0.07	0.00